BioClinica moves to private equity, merges with CoreLab Partners

Just 48 hours after completing a move to private equity funding, imaging and eClinical service provider BioClinica has merged with one of its leading competitors, CoreLab Partners, to form a single service offering across imaging core lab services, cardiovascular safety monitoring, and eClinical trial management.

The move combines BioClinica’s track-record in areas such as oncology, neurology and muskuloskeletal with CoreLab’s cardiovascular safety monitoring services. The move also enables the company to offer global support, with offices in North America, Japan, China and across Europe.

The combined company will retain the name BioClinica, and Mark Weinstein will remain at the helm as CEO.